GGT5 Is an Independent Prognostic Biomarker in Stomach Adenocarcinoma

Gastric cancer is one of the cancers with the highest incidence in the world. Gamma-glutamyltransferase 5 (GGT5) is expressed in different cancers and its role in cancers remains unclear. In this study, we aimed to evaluate the value of GGT5 in stomach adenocarcinoma (STAD). In TCGA, patients with h...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yong, Zhou, HaiLang, Zou, Junwei, Wang, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898138/
https://www.ncbi.nlm.nih.gov/pubmed/35257007
http://dx.doi.org/10.1155/2022/9983351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898138/
https://www.ncbi.nlm.nih.gov/pubmed/35257007
http://dx.doi.org/10.1155/2022/9983351

Ejemplares similares